Skip to main content
. Author manuscript; available in PMC: 2018 Jun 5.
Published in final edited form as: Genet Med. 2015 May 21;18(2):189–198. doi: 10.1038/gim.2015.60

Table 3. Rare Non-Synonymous Variants in Prioritized AVSD Genes.

Gene Genomic Position Base Change Amino Acid Change Rare or Novel* Predicted Damaging?* Conserved?* Proband ID
NIPBL 5:36958288 A>G N105D Rare Yes Yes AVSD_88
NIPBL 5:36962301 G>A A179T Rare No Yes AVSD_65
NIPBL 5:36976188 T>G N393K Novel No Yes AVSD_15
AVSD_72
NIPBL 5:37006555 A>G M1318V Novel Yes Yes AVSD_33
NIPBL 5:37058993 T>A S2471T Novel Yes Yes AVSD_25
CHD7 8:61654268 A>G T93A Novel No Yes AVSD_15
CHD7 8:61655009 A>G M340V Rare No Yes AVSD_13
AVSD_50
AVSD_66
AVSD_71
CHD7 8:61748826 T>C Y1325H Rare Yes Yes AVSD_79
CHD7 8:61765598 C>T A2105V Novel Yes Yes AVSD_26
CHD7 8:61768745+ C>G S2383C Novel Yes Yes AVSD_49
CHD7 8:61769418 A>C M2527L Rare No Yes AVSD_73
CEP152 15:49030841 T>C T1524A Rare No No AVSD_19
CEP152 15:49048132 G>C L1105V Rare No No AVSD_20
CEP152 15:49048567 A>G W960R Rare Yes Yes AVSD_63
AVSD_64
AVSD_72
CEP152 15:49064725 G>T L581I Novel Yes No AVSD_41
CEP152 15:49076311 T>C I394V Rare No No AVSD_15
CEP152 15:49089864 A>C S85R Rare No No AVSD_38
BMPR1a 10:88681396 A>T D429V Novel Yes Yes AVSD_17
BMPR1a 10:88683223 G>A R478H Rare Yes Yes AVSD_57
BMPR1a 10:88683231 C>T P481S Novel Yes Yes AVSD_2
ZFPM2 8:106431420 A>G E30G Rare Yes Yes AVSD_53
AVSD_74
ZFPM2 8:106456600 G>A D98N Rare Yes Yes AVSD_25
AVSD_10
AVSD_24
ZFPM2 8:106813787 C>T P361S Rare Yes Yes AVSD_53
ZFPM2 8:106813942 G>A M544I Rare No Yes AVSD_38
AVSD_46
ZFPM2 8:106814597 G>A V631I Rare Yes Yes AVSD_74
AVSD_50
ZFPM2 8:106815359 G>A G885S Rare No Yes AVSD_45
MDM4 1:204518457 A>C K324Q Rare Yes Yes AVSD_10
AVSD_39
AVSD_80
AVSD_85
AVSD_87
MDM4 1:204518499 C>G P338A Rare Yes Yes AVSD_29

* Genomic position for human genome assembly 37/build 105. ** Refer to the Supplementary Table 4 for additional detail + With the exception of this variant, all variants in Table 3 were covered to a depth of ≥ 30 in the AVSD and EVS cohorts (nucleotide-by-nucleotide coverage assessment)